Skip to main content
OpenTrials

Clinical trial condition

Glycogen Storage Disease Type II

Explore clinical trials studying Glycogen Storage Disease Type II. Study availability and eligibility vary by location and protocol.

105 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Glycogen Storage Disease Type II trial results

Completed

Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.

NCT01898364

Conditions
Acid Maltase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +15 more
Locations
  • Investigational Site Number 840006 Phoenix, Arizona, United States
  • Investigational Site Number 840010 Jacksonville, Florida, United States
  • Investigational Site Number 840001 Kansas City, Kansas, United States
  • Investigational Site Number 840008 St Louis, Missouri, United States
View all 17 locations
View Trial Details
Completed

Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness

NCT02746718

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • CHU d'Angers Angers, France
  • Centre hospitalier d'Argenteuil Argenteuil, France
  • CHU de Brest Brest, France
  • CH d'Escartons Briançon, France
View all 21 locations
View Trial Details
Completed

Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease

NCT04120168

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
Locations
  • Adana City Hospital Adana, Turkey (Türkiye)
  • Baskent University Adana Hospital Adana, Turkey (Türkiye)
  • Çukurova University Faculty of Medicine, Pediatric Gastroenterology Adana, Turkey (Türkiye)
  • Afyonkarahisar Health Sciences University Afyonkarahisar, Turkey (Türkiye)
View all 51 locations
View Trial Details
Completed

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

NCT02140151

Conditions
Age-Related Macular Degeneration, Brain Diseases, Brain Diseases, Metabolic, +18 more
Locations
  • Northern California Retina Vitreous Associates Mountain View, California, United States
  • Southern California Desert Retina Consultants Palm Desert, California, United States
  • Elman Retina Baltimore, Maryland, United States
  • Black Hills Regional Eye Institute Rapid City, South Dakota, United States
View Trial Details
Completed

Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease

NCT01410890

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Investigational Site Number 840008 Valhalla, New York, United States
  • Investigational Site Number 840007 Cincinnati, Ohio, United States
  • Investigational Site Number 840005 Salt Lake City, Utah, United States
  • Investigational Site Number 840003 Fairfax, Virginia, United States
View Trial Details

Related conditions